NASDAQ: AEGR
Price:
28.75
Change:
+ 1.07
Day High:
28.92
Day Low:
27.82
Volume:
978,000
4:00 PM ET on Jul 23, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Press Releases


All 2014 Releases
View Summary Aegerion Pharmaceuticals to Announce Second Quarter 2014 Financial Results on Tuesday, July 29
Jul 22, 2014
PDF 9.9 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Jul 9, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Jun 6, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at the Jefferies 2014 Global Healthcare Conference
May 28, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
May 7, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces First-Quarter 2014 Financial Results
May 6, 2014
PDF 24.2 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences
Apr 30, 2014
PDF 10.2 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Announce First Quarter 2014 Financial Results on Tuesday, May 6
Apr 30, 2014
PDF 9.8 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Initiates Phase 3 Clinical Trial in Japan to Evaluate Lomitapide for Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Apr 9, 2014
PDF 12.6 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Apr 7, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Mar 7, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Observes Rare Disease Day
Feb 28, 2014
PDF 10.4 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at the Cowen and Company Healthcare Conference
Feb 27, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2013 Financial Results
Feb 26, 2014
PDF 26.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2013 Financial Results on Wednesday, February 26
Feb 13, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals' JUXTAPID(TM) (lomitapide) Capsules Approved in Canada for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Feb 10, 2014
PDF 63.8 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Feb 7, 2014
PDF 10.0 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Announces Presentation at Leerink Global Healthcare Conference
Feb 6, 2014
PDF 10.1 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals' JUXTAPID(R) (lomitapide) Capsules Approved in Mexico for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Jan 20, 2014
PDF 65.3 KB Add to Briefcase
View Summary Aegerion Pharmaceuticals Reports Preliminary 2013 Net Product Sales, Its Outlook for 2014 and Other Business Updates
Jan 9, 2014
PDF 14.3 KB Add to Briefcase
Showing 1-20 of 22 Page: 1 2  Next 20
Add to Briefcase = add release to Briefcase